EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseOpen Access · CC BY-NC 4.0

Survival Outcomes of Breast-Conserving Surgery Versus Mastectomy in Locally Advanced Breast Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis

Rong Qin, Liang Yin iD, Deqian Wang, Xuan Cao, Zakari Shaibu, Xiangyang Wang, Peiqin Chen, Danjuan Sui, Xiaoxi Qiu, Dan Liu

Technology in Cancer Research & Treatment · 2024-01 · 23

DOI: 10.1177/15330338241265030 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 23.07.2024. Verfasst von Rong Qin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Jiangsu University Affiliated People's Hospital, Zhenjiang Clinical Medical College of Nanjing Medical University, Zh…. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Segmental, Neoadjuvant Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Project of Zhenjiang City Social Development, Jiangsu Province Maternal and Child Health Research Project, Jiangsu University Medical Education and Research Collaborative Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mastectomy (MT) and breast conservation surgery (BCS) are two common surgical options for the treatment of locally advanced breast cancer (LABC). Neoadjuvant chemotherapy (NACT) is frequently administered before surgery to shrink tumors and improve surgical outcomes. However, there is a lack of consensus on the optimal surgical approach after NACT and its impact on survival outcomes.

Objective

This meta-analysis aims to compare the survival outcomes between MT and BCS in patients treated with NACT.

Method

A PRISMA selection was used to identify studies across electronic database such as PubMed, and Cochrane Library from inception until 11 th July, 2023. A total of 10 comparative studies involving a total of 5018 patients were included. Among them, 2898 patients underwent MT while 2120 underwent BCS after receiving NACT. The outcomes assessed were the 5-year overall survival (OS) and 5-year disease-free survival (DFS). The data from the included studies were pooled, and odds ratios (OR) with 95% confidence intervals (CI) were calculated to evaluate the differences between MT and BCS in terms of survival outcomes. Prospero: CRD42024496831.

Result

The meta-analysis revealed that patients who underwent MT after NACT had a higher 5-year OS compared to those who underwent BCS (OR 2.68, 95% CI [2.19-3.28; p < 0.00001]). Additionally, the 5-year DFS was significantly better for patients who underwent MT (OR 3.11, 95% CI [1.80-5.38; p < 0.0001]).

Conclusion

MT after NACT may be associated with better 5-year OS and DFS compared to BCS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMastectomy, SegmentalNeoadjuvant TherapyFemaleHumansAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyMastectomyNeoplasm StagingOdds RatioTreatment Outcome

Stichwörter der Autor:innen

breast cancerchemotherapy treatmentlocally advanced breast-Conservingmastectomyneoadjuvantsurgery

Autor:innen und Institutionen

  • Department of Medical Oncology, Jiangsu University Affiliated People's Hospital, Zhenjiang Clinical Medical College of Nanjing Medical University, Zhenjiang, China.
  • Department of Breast Surgery, Jiangsu University Affiliated People's Hospital, Zhenjiang, China.
  • School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
  • Department of Traditional Chinese Medicine, Jiangsu University Affiliated People's Hospital, Zhenjiang, China.
  • Department of Pharmacy, Jiangsu University Affiliated People's Hospital, Zhenjiang, China.
  • Nursing Department, Heyang County People's Hospital, Weinan City, Shaanxi Province, China.

ORCID-Profile: Liang Yin

Förderung

  • Project of Zhenjiang City Social Development
  • Jiangsu Province Maternal and Child Health Research Project
  • Jiangsu University Medical Education and Research Collaborative Innovation Fund
  • Jiangsu Research Hospital Association for Precision Medication Project number
  • Clinical Research Project of the Jiangsu University Affiliated People's Hospital

Zitieren

APA

Qin, R., Yin, L., Wang, D., Cao, X., Shaibu, Z., Wang, X., Chen, P., Sui, D., Qiu, X., & Liu, D. (2024). Survival Outcomes of Breast-Conserving Surgery Versus Mastectomy in Locally Advanced Breast Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis. Technology in Cancer Research & Treatment, 23. https://doi.org/10.1177/15330338241265030

Vancouver

Qin R, Yin L, Wang D, Cao X, Shaibu Z, Wang X, et al. Survival Outcomes of Breast-Conserving Surgery Versus Mastectomy in Locally Advanced Breast Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis. Technology in Cancer Research & Treatment. 2024;23. doi:10.1177/15330338241265030

BibTeX
@article{Qin2024,
  author = {Qin, Rong and Yin, Liang and Wang, Deqian and Cao, Xuan and Shaibu, Zakari and Wang, Xiangyang and Chen, Peiqin and Sui, Danjuan and Qiu, Xiaoxi and Liu, Dan},
  title = {Survival Outcomes of Breast-Conserving Surgery Versus Mastectomy in Locally Advanced Breast Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis},
  journal = {Technology in Cancer Research & Treatment},
  year = {2024},
  volume = {23},
  doi = {10.1177/15330338241265030}
}
Kostenlos starten →